Circadian changes in granulocyte-macrophage colony-stimulating factor message in circulating eosinophils.

[1]  S. Esnault,et al.  The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils , 2005, Nature Immunology.

[2]  E. R. Sutherland,et al.  Nocturnal asthma: underlying mechanisms and treatment , 2005, Current allergy and asthma reports.

[3]  E. A. Kelly,et al.  Inflammatory changes associated with circadian variation in pulmonary function in subjects with mild asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  S. Esnault,et al.  Hyaluronic Acid or TNF-α Plus Fibronectin Triggers Granulocyte Macrophage-Colony-Stimulating Factor mRNA Stabilization in Eosinophils Yet Engages Differential Intracellular Pathways and mRNA Binding Proteins1 , 2003, The Journal of Immunology.

[5]  B. Bochner,et al.  Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. , 2003, Blood.

[6]  Konstantin G. Chernov,et al.  The mRNA-binding Protein YB-1 (p50) Prevents Association of the Eukaryotic Initiation Factor eIF4G with mRNA and Inhibits Protein Synthesis at the Initiation Stage* , 2003, The Journal of Biological Chemistry.

[7]  N. Jarjour,et al.  Circadian variation of sputum inflammatory cells in mild asthma. , 2003, The Journal of allergy and clinical immunology.

[8]  S. Esnault,et al.  Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-alpha plus fibronectin-activated peripheral blood eosinophils. , 2002, Blood.

[9]  S. Wenzel,et al.  Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation. , 2002, American journal of respiratory cell and molecular biology.

[10]  S. Esnault,et al.  Y Box-Binding Factor Promotes Eosinophil Survival by Stabilizing Granulocyte-Macrophage Colony-Stimulating Factor mRNA1 , 2001, The Journal of Immunology.

[11]  N. Sonenberg,et al.  The major mRNA‐associated protein YB‐1 is a potent 5′ cap‐dependent mRNA stabilizer , 2001, The EMBO journal.

[12]  S. Esnault,et al.  Granulocyte Macrophage-Colony-Stimulating Factor mRNA Is Stabilized in Airway Eosinophils and Peripheral Blood Eosinophils Activated by TNF-α Plus Fibronectin1 , 2001, The Journal of Immunology.

[13]  S. Esnault,et al.  Minute quantities of granulocyte-macrophage colony-stimulating factor prolong eosinophil survival. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[14]  M. Mann,et al.  Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. , 2000, Genes & development.

[15]  W. Busse,et al.  Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. , 1999, American journal of respiratory and critical care medicine.

[16]  B. Wedi,et al.  IL-4-induced apoptosis in peripheral blood eosinophils. , 1998, The Journal of allergy and clinical immunology.

[17]  T. Lee,et al.  Cultured human airway smooth muscle cells stimulated by interleukin-1beta enhance eosinophil survival. , 1998, American journal of respiratory cell and molecular biology.

[18]  S. Esnault,et al.  Stabilization of granulocyte-macrophage colony-stimulating factor RNA in a human eosinophil-like cell line requires the AUUUA motifs. , 1998, Proceedings of the Association of American Physicians.

[19]  W. Busse,et al.  Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. , 1998, Journal of immunology.

[20]  C. Bachert,et al.  Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. , 1997, Journal of immunology.

[21]  R. Djukanović,et al.  Alveolar tissue inflammation in asthma. , 1996, American journal of respiratory and critical care medicine.

[22]  J. Malter,et al.  Turnover and Translation of in Vitro Synthesized Messenger RNAs in Transfected, Normal Cells* , 1996, The Journal of Biological Chemistry.

[23]  W. Busse,et al.  Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. , 1995, American journal of respiratory and critical care medicine.

[24]  C. Roberts,et al.  Is asthma a fibrotic disease? , 1995, Chest.

[25]  W. Busse,et al.  Relationship of plasma epinephrine and circulating eosinophils to nocturnal asthma. , 1994, American journal of respiratory and critical care medicine.

[26]  N. Douglas,et al.  Role of inflammation in nocturnal asthma. , 1994, Thorax.

[27]  W. Busse,et al.  Enhanced production of oxygen radicals in nocturnal asthma. , 1992, The American review of respiratory disease.

[28]  L. Ovchinnikov,et al.  Role of cytoplasmic mRNP proteins in translation. , 1992, Biochimie.

[29]  L. Ackerson,et al.  Stability of the circadian alteration in lung function in asthma. , 1992, The Journal of allergy and clinical immunology.

[30]  W. Busse,et al.  Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. , 1992, The American review of respiratory disease.

[31]  H. Kita,et al.  Glucocorticoids inhibit cytokine-mediated eosinophil survival. , 1991, Journal of immunology.

[32]  H. Kita,et al.  Materials and Methods Brief Definitive Report Granulocyte/macrophage Colony-stimulating Factor and Interleukin 3 Release from Human Peripheral Blood Eosinophils and Neutrophils , 2022 .

[33]  A. Wardlaw,et al.  Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils , 1991, The Journal of experimental medicine.

[34]  G. Firestein,et al.  Endobronchial allergen challenge in asthma. Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization. , 1991, The Journal of clinical investigation.

[35]  R. Ballard,et al.  Airways inflammation in nocturnal asthma. , 1991, The American review of respiratory disease.

[36]  R. Martin,et al.  Plasma histamine, epinephrine, cortisol, and leukocyte β‐adrenergic receptors in nocturnal asthma , 1991, Clinical pharmacology and therapeutics.

[37]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[38]  S. Holgate,et al.  SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.

[39]  C. Dollery,et al.  Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. , 1980, The New England journal of medicine.

[40]  A. Cats,et al.  HL-A 27 AND ANKYLOSING SPONDYLITIS , 1975, The Lancet.

[41]  T. Hacken.  Airway inflammation in nocturnal asthma , 1998 .